Michael G. Schlossmacher

University of Ottawa — Canada

Medicine · Health Sciences

56h-index15.8kcitations163works4.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Parkinson's Disease Mechanisms and Treatments(108), Neurological disorders and treatments(41), Nuclear Receptors and Signaling(40), Alzheimer's disease research and treatments(27), Neurological diseases and metabolism(15)

Publications158 total

Feasibility of Simon Two‐Stage Futility Trials in People with Early, Symptomatically Treated Parkinson's Disease
Movement Disorders·2025Open Access
Quantitative measurements of α-synuclein seeds in CSF inform diagnosis of synucleinopathies
Journal of Parkinson s Disease·2025· 3 citedOpen Access
Elevated brain α-synuclein, phosphorylated-tau, and oxidative stress in mice that survived influenza A pneumonitis
2025Open Access
Optogenetic stimulation of nigral astrocytes is neuroprotective in a 6-OHDA model of neurodegeneration
2025Open Access
Variants in Lrrk2 and Snca deficiency do not alter the course of primary encephalitis due to neurotropic reovirus T3D in newborn mice
PLoS ONE·2025Open Access
Development of a simplified smell test to identify Parkinson’s disease using multiple cohorts, machine learning and item response theory
npj Parkinson s Disease·2025· 2 citedOpen Access
Race and ethnicity matter! Moving Parkinson’s risk research towards diversity and inclusiveness
npj Parkinson s Disease·2025· 9 citedOpen Access
Quantitative Measurements of α-Synuclein Seeds in CSF Inform Diagnosis of Synucleinopathies
2025Open Access
Feasibility of Simon 2-Stage Futility Trials in Early Parkinson Disease
Neurology·2024· 2 citedOpen Access
A Protocol for Neuralized Murine Olfactory Organoids
2024Open Access
Disease-modifying therapies for Parkinson disease: lessons from multiple sclerosis
Nature Reviews Neurology·2024· 18 cited
Variants in <i>Lrrk2</i> and <i>Snca</i> deficiency do not alter the course of primary encephalitis due to neurotropic reovirus T3D in newborn mice
2024Open Access
Advancing Parkinson’s Disease Research in Canada: The Canadian Open Parkinson Network (C-OPN) Cohort
Journal of Parkinson s Disease·2024· 8 citedOpen Access
Correction: Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19
Acta Neuropathologica Communications·2024· 1 citedOpen Access
Development of a Simplified Smell Test to Identify Patients with Typical Parkinson’s as Informed by Multiple Cohorts, Machine Learning and External Validation
2024· 1 citedOpen Access
ADVANCING PARKINSON’S DISEASE RESEARCH IN CANADA: THE CANADIAN OPEN PARKINSON NETWORK (C-OPN) COHORT
2024Open Access
Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19
Acta Neuropathologica Communications·2024· 3 citedOpen Access
Genetic and pharmacological reduction of CDK14 mitigates synucleinopathy
Cell Death and Disease·2024· 6 citedOpen Access
A topographical atlas of α-synuclein dosage and cell type-specific expression in adult mouse brain and peripheral organs
npj Parkinson s Disease·2024· 25 citedOpen Access
Unraveling the assembloid: Real-time monitoring of dopaminergic neurites in an inter-organoid pathway connecting midbrain and striatal regions
Materials Today Bio·2024· 10 citedOpen Access
page 1 of 8Next →

Frequent Co-authors

Brit Mollenhauer(13), Dennis J. Selkoe(10), Joseph J. Locascio(9), Claudia Trenkwalder(7), Clemens R. Scherzer(7), Albert Y. Hung(6), Omar M. A. El‐Agnaf(5), Zhixiang Liao(5), Juliana Ng(5), Christine Klein(5), David S. Park(5), Friederike Sixel‐Döring(4), Michael A. Schwarzschild(4), Lewis Sudarsky(4), Valerie Cullen(4), Bradley T. Hyman(4), John Woulfe(4), Ana Trisini‐Lipsanopoulos(4), Christian Haass(3), Beth L. Ostaszewski(3)